Procalcitonin (PCT) has emerged as the most promising marker of infectious inflammation. This development is critical to the practicing doctor dealing with febrile patients with suspected sepsis. An ideal biomarker would provide data for early diagnosis, differentiation of bacterial from non-bacterial causes of inflammation and information about the clinical course and prognosis of the disease. PCT is an early biomarker that is present within 3 to 4 hours of the triggering infection. An undetectable PCT level would efficiently rule out systemic infection. PCT may also be viewed as a marker of resolving infection as it has a half-life of about 22 hours, and its blood level correlates with bacterial load. Thus, PCT may be used as a clinical tool for early diagnosis, prognosis and therapeutic guide. Automated platforms with short assay times and service that is available 24 hours a day have enabled clinicians to obtain rapid reliable results for the early diagnosis and timely monitoring of appropriate pharmacotherapy. Clinicians should use PCT as an adjunct to clinical and other diagnostic criteria.
INTRODUCTION
Evaluation of possible sepsis is a key consideration in the practice of infectious disease. Clinical parameters (temperature, BP, heart rate, respiration rate) remain a cornerstone in the evaluation of sepsis. Many clinicians continue to rely on traditional markers like white blood cell (WBC) count, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Final microbial confirmation is only afforded by 2-3 sets of blood culture (BC) which remains the gold standard 1 for sepsis diagnosis. However, the 2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference has shifted the definition of sepsis away from a microbiological one towards consideration of host response and organ dysfunction 2 . Their PIRO model (mnemonics for predisposition, insult infection, response and organ dysfunction) has redefined sepsis as infection in the presence of some general and early inflammatory variables 3 including procalcitonin (PCT), CRP and WBC. Despite advances in the diagnosis 4 and management 5 , sepsis continues to be a growing problem especially in the elderly and patients in intensive care units (ICU).
Procalcitonin has made its mark as a significant biomarker of sepsis and antibiotic stewardship 6, 7 .
Clinicians should thus be more aware of this laboratory analyte. In this article we seek to provide the salient background information for the practicing doctor.
Pathobiology of Sepsis and Procalcitonin
The pathophysiology of sepsis is complex and has been recently reviewed 8, 9 . Molecular biology has provided new insights into the complexity of the pathogen-host response in which proinflammatory and anti-inflammatory mechanisms contribute to the clearance of infection. Besides tissue recovery, multiple organ injury and secondary infections may also prevail.
The pathophysiology of PCT is equally complex 6, 7, 10 . Procalcitonin is a prohormone (precursor) of calcitonin (CT). Procalcitonin is a member of the Proceedings of Singapore Healthcare  Volume 23  Number 1  2014 CAPA family of proteins. The biological role of calcitonin and its prohormone remains unclear. Following transcription (CALC-1 gene) and translation (calcitonin-mRNA), pre-PCT is formed. Thereafter it is cleaved to PCT, a 116 amino-acid moiety. Further enzymatic modifications yield the 32 amino-acid hormone CT. Normally, CALC-1 gene activity is confined to the neuroendocrine cells of the thyroid and lung and very little is present in the circulation (<0.05 ng/mL) 11 .
In response to inflammatory triggers (e.g. injury, burns, and infection) humoral factors are released and the complement and coagulation cascades activated. The slew of secreted factors include acute phase proteins (e.g. CRP, PTX-3), stress hormones (e.g. catecholamines), hormokines (e.g. calcitonin and its precursors, adrenomedullin, IL-6), intracellular factors (e.g. heat shock proteins), and cytokines (immuno-regulatory, pro-inflammatory, and anti-inflammatory) 10 . In infections and systemic inflammation, marked increase in PCT (hyper-PCTemia) occurs within two to four hours and peaks at four to 20 hours later. This may be contributed, in part, by adipose tissue directly through its resident immune cells or indirectly through endocrine and/or paracrine modulation of immune function 12 .During inflammation, expression of adipose tissue TNF-alpha increases markedly and is believed to exert its effects locally. TNF-alpha is not secreted into the circulation, while another adipokine, IL-6, is briskly released into the blood stream. Adipokines have only been a recent subject of study. In sepsis, adipocyte calcitonin and procalcitonin expression is increased a thousandfold with consequent increase of PCT but not CT in the blood stream. This elevation in PCT correlates with disease severity and mortality.
Procalcitonin was first identified as a possible sepsis biomarker in 1993 11 . Procalcitonin increases within four hours after a bacterial infection and declines when the infection is controlled. In contrast, elevations in CRP and ESR only occur after 24 hours and are raised in viral infections while PCT is often normal as its up-regulation is attenuated by the release of viremia-associated interferongamma 10 . Procalcitonin is also unaffected by therapy with steroids 13 .
SPECIMEN
Serum and plasma (heparin or EDTA) may be used for testing. Samples should be taken initially and serially thereafter to monitor the patient's response to treatment since PCT remains elevated as long as the inflammatory process continues. Persistently elevated PCT levels suggest the continued presence of infection 11 . PCT remains stable during blood sample processing, freezing and long-term storage 14 .
INDICATIONS
Procalcitonin has a role in diagnosis, prognosis and in guiding antibiotic therapy.
Diagnosis
In current clinical practice, PCT is used as an indicator of bacteremia and bacterial load prior to blood culture confirmation since blood cultures have intrinsic issues such as diagnostic delay, low sensitivity and poor specificity. PCT has emerged as the most promising biomarker for sepsis and bacteremia as it can be objectively measured and rapidly evaluated to aid decision making in patient care. Its reported diagnostic accuracy is high-sensitivity 74.8-100%, specificity 70-100%, positive predictive value (PPV) 55-100% and negative predictive value (NPV) 56.3-100% 15 . Rapid diagnosis is important in patient care as any delay in antimicrobial administration increases morbidity and mortality. When sepsis escalates to septic shock, acute kidney injury may ensue. When PCT levels are low (<0.1 ng/mL), bacteremia and sepsis are unlikely -NPV 98.2%, sensitivity 75%, specificity 78% 16 .
As a biomarker for bacterial infection, most studies find PCT useful and accurate for bacterial infection and superior to other common inflammatory markers such as CRP. A very recent comprehensive review (3487 reports) of PCT as a diagnostic marker for sepsis concludes that PCT, together with careful clinical parameters, can discriminate infective from non-infective causes of sepsis in 77% of cases 17 .
Several recent reviews on biomarkers are positive about the use of PCT in pulmonary disorders [18] [19] [20] .
Among neutropenic patients (absolute neutrophil count <0.5x10 9 /L), PCT has been found to be elevated in acute myeloid leukemia 21 , cancer patients at the Emergency Department 22 ,pediatric oncology patients 23 , and in hematological patients 24 . However, meta-analysis could not arrive at a definitive conclusion that PCT can predict adverse consequences in patients with febrile neutropenia 25 .
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In the post-operative period PCT may also be useful in the diagnosis of bacterial infections [26] [27] .
Differential Diagnosis
Procalcitonin may be used for the differential diagnosis of bacterial versus viral systemic infections. Patients with bacterial pneumonia are expected to have high PCT levels whereas those with viral respiratory infection have low PCT levels 11, 28 . A low PCT level rules out bacterial infection and provides an opportunity for appropriate treatment by anti-viral or other treatments. The PCT level has also been shown to be a good biomarker to distinguish between bacterial versus viral causes of meningitis 29 , febrile respiratory illness in the emergency department 30 , and communityacquired pneumonia 31, 32 . Equally, fungal infections tend to evoke only minimal elevations in PCT 11 .
Prognosis
The prognostic value of PCT has been noted. Procalcitonin levels correlate with the severity of pneumonia. In 185 patients with community acquired pneumonia (CAP), higher PCT levels were observed in the more severe cases; those with PCT>0.5 ng/mL had higher mortality 33 . Procalcitonin has been shown to increase with increasing degrees of sepsis and organ dysfunction 34 . In the surgical ICU, septic patients showing a PCT drop of more than 50% and a combined PCT decrease of more than 75% with a CRP drop of more than 25% on day 7 have a more favorable outcome 35 . Higher PCT levels in sepsis is predictive of poorer survival. The greater the peak PCT levels the higher is the 90-day mortality; 1-5 ng/mL -11%, 51-100 ng/mL -42%. With increasing severity of CAP, PCT levels are higher in non-survivors than in survivors 36 .
Therapeutic Guide
Procalcitonin-guided treatment decisions in respiratory infections have been successful in decreasing prescriptions (primary care) and shortening courses of antibiotics (ED and ICU). This has been re-affirmed in a recent summary of 14 such trials involving 4211 patients 37 . Sequential PCT testing to determine when to discontinue antibiotics in hospitalised patients with pneumonia or sepsis is the most useful indication for the use of PCT.
In-depth analyses of clinical trials investigating the use of PCT for antimicrobial stewardship show no significant difference in mortality or relapse of infection between treatment groups 38, 39 . A significant reduction in antibiotic exposure as well as length of ICU stay was observed.
ASSAY METHODS
The availability of rapid, automated, random access immunoassays for PCT 15 has made this test available for rapid screening and triaging of patients as well as risk assessment of the critically ill in intensive care units. The Elecsys (Roche-BRAHMS) electrochemiluminescence method has an assay time of 18 minutes and detection limit of 0.06 ng/mL while the Vidas (Biomerieux) enzyme-linked fluorescence immunoassay takes 20 minutes with 0.09 ng/mL as the limit of detection limit. The Kryptor (BRAHMS) time-resolved amplified cryptate emission (TRACE) method has a comparable detection limit of 0.06 ng/mL, but takes longer (50 minutes). The lesssensitive (0.5 ng/mL) older method (LUMItest, BRAHMS) is still available and is not recommended as it is unable to reliably separate normal subjects (<0.05 ng/mL) from patients. All the PCT methods use the BRAHMS antibody and give results which are generally comparable. However, the Roche PCT assay appears to be aligned to the older BRAHMS Kryptor method and will give lower PCT values compared to the BRAHMS VIDAS (BioMerieux) and ADVIA (Siemens) assays.
LIMITATIONS
Following exercise, serum PCT levels increase naturally after 3-24 h 40 . In newborn infants, PCT also rises naturally to 2-3 ng/mL at 24 hours after birth and decline to normal levels at 48-72 hours 41 . Procalcitonin may be elevated in aseptic conditions such as medullary thyroid cancer, small cell lung cancer, postoperative complications, cirrhosis, pancreatitis, ischemic bowel and cardiogenic shock 11, 40 . Some sepsis patients may not have raised PCT levels while others with elevated values do not have sepsis. The PIRO model sets the cut-off value to rule-out sepsis at >2 standard deviations above the normal, but this "normal" varies as it is decision-based and method dependent. The lack of a definitive cut-off in addition to individual biological variation for PCT production may cloud interpretation of test results. As a diagnostic tool, PCT alone may not be useful when values are in the indeterminate zone 42 . However, PCT may Proceedings of Singapore Healthcare  Volume 23  Number 1  2014 help when employed in combination with other inflammation biomarkers.
OUR EXPERIENCE
We reviewed the results of 627 patients in our institution who had the following parameters ordered -PCT (electrochemiluminescent immunoassay, Cobas 6000, Roche), hsCRP (immunoturbidimetry, Synchron LX20, Beckman Coulter), WBC (Cell-Dyn Ruby, Abbott Diagnostics) and microbiology blood cultures -between June and September 2008. Patients were divided into two groups according to their final culture results: those with infection and those without infection. We set up a decision tree where leucocytosis (>10x10 9 cells/L) and positive blood cultures made up the first and second decision nodes for bacteremia. Procalcitonin at cut-off values of 0.5 and 2.0 ng/mL were used as the final decision limits. A similar decision tree was drawn for hsCRP with the final decision nodes at cut-off values of 2.0 and 10.0 mg/L, respectively. (see Table 1 ).
Compared to hsCRP, PCT has reasonable sensitivity but superior specificity for culture positive bacterial infection and performs better in those with leukocytosis 43 .
CONCLUSION
Procalcitonin has shown to be a good biomarker for diagnosing sepsis in febrile subjects and also for evaluating its severity in an emergency setting while awaiting confirmation from blood culture results. However, definitive cut-off points differ by assay, study, and clinical circumstance. Procalcitonin should be interpreted in conjunction with the other diagnostic criteria for sepsis. The change in and velocity of PCT increase rather than the absolute values may be more useful in prognosis and in guiding antibiotic therapy. 
